← Eichor
Study identifier: NCT06558487 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

The Internal Prospective Validation of the Cancer Admission Score (CAS) Prediction Model

Condition: Oncology  ·  Sponsor: Erasmus Medical Center

PhaseN/A
Planned participants200
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The goal of this single center prospective observational study is to determine the agreement between the cancer admission score (CAS) predicted disposition and the actual disposition in patients with an active cancer diagnosis visiting the emergency department (ED). The main question it aims to answer are: Is the performance of the CAS good enough to play a potential role in the ED care process. For each participant the CAS will be calculated and compared to the actual outcome.

This description comes directly from the study's public registry record.

Talk to the study team

Jason den Duijn  ·  0107040704  ·  j.denduijn@erasmusmc.nl

Always discuss trial participation with your own doctor first.

Locations (1)

Erasmus University Medical CenterRotterdam, South Holland, NetherlandsRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06558487